We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meetings and Open Offer

25 Jul 2016 12:34

RNS Number : 1376F
Frontier Resources International
25 July 2016
 

25 July 2016 

Frontier Resources International plc

('Frontier Resources International' or the 'Company') to be renamed Concepta PLC

RESULT OF GENERAL MEETINGS AND OPEN OFFER

Result of Meetings

Frontier Resources International plc (AIM:FRI) announces that, at the General Meetings of the Company held earlier today, all resolutions were duly passed.

The Share Consolidation, whereby every 250 existing ordinary shares of 0.01p will be consolidated into 1 new ordinary share of 2.5p ("New Ordinary Shares"), and such that the 5,200,000,000 existing ordinary shares of 0.01p are consolidated into 20,800,000 New Ordinary Shares will take place at 5.00pm this evening.

The change of the Company's name to Concepta PLC (AIM: CPT), a pioneering UK healthcare company that has developed proprietary products and a platform, which targets the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility, will become effective upon the registration of the Company's change of name at Companies House, and is expected later this afternoon. A further announcement will be made in due course.

Additionally, the following proposals become unconditional in all respects upon Admission of the Enlarged Share Capital to trading on AIM, which is expected to occur at 8.00 a.m. on Tuesday 26 July 2016:

· the acquisition by the Company of the entire issued share capital of Concepta Diagnostics Limited, resulting in the issue of 30,343,950 New Ordinary Shares;

· the issue of 32,050,342 New Ordinary Shares under the Firm Placing, 1,373,330 New Ordinary Shares under the Subscription, 10,833,333 New Ordinary Shares under the Debt Conversion, 13,759,618 New Ordinary Shares under the Conditional Placing with clawback under the Open Offer (see below under "Open Offer"); and

· Erik Henau and Dr Mark Wyatt join the Board as Chief Executive and Non-Executive Director respectively.

The Enlarged Ordinary Share Capital of the Company, comprising 109,160,573 New Ordinary Shares, will trade under the ISIN GB00BYZ2R301.

Open Offer

The Company received valid applications under the Open Offer from Qualifying Shareholders in respect of 26,987,695 New Ordinary Shares, representing 196% of the 13,759,618 shares available under the Open Offer. As a result, excess applications have been scaled back in accordance with the Terms & Conditions of the Open Offer. Qualifying Shareholders who subscribed for excess shares will be notified of their allocations shortly by post.

The Offer Shares have been clawed back from the conditional placees, as set out in the Company's announcement of 7 July 2016.

 

 

 

Terms defined in the Admission Document (which was issued on 7 July 2016) have the same meaning in this announcement. A copy of the Admission Document can also be viewed on the Company's website.

Following Admission of all the shares referred to above, the shares held by members of the Concert Party, and as a percentage of the Enlarged Share Capital will be as follows:

 

Name

Number of Shares

% of Enlarged Share Capital

Steven Lee

2,412,050

2.21

Michael Catt

2,240,100

2.05

Zhang Zhi Gang

2,461,783

2.26

Robert Porter

2,528,450

2.32

Angel Co Fund

11,668,267

10.69

David Evans

2,834,033

2.60

Neil McArthur

1,999,750

1.83

Clare Hughes

1,999,750

1.83

Andrew Parker

1,333,800

1.22

Steven Lister/ Debbie Heath

1,000,350

0.92

David Groves

666,900

0.61

Alan Halsall

666,900

0.61

David Gare

266,950

0.24

Richard Faulkner

66,500

0.06

Adam Reynolds

1,155,555

1.06

Total

33,301,138

30.51

 

In addition, the holdings of other directors following their previously announced participation in the Open Offer are as follows:

Name No of shares held % of Enlarged Share Capital

Barbara Spurrier 246,057* 0.23%

* 100,952 of these shares are held by CFPro Limited, a company with which Barbara Spurrier is connected.

Buyback of deferred shares

The Company has now bought back all the Deferred Shares of 0.9p each and all of the "A" Deferred Shares of 0.09p each, and all such shares have now been cancelled.

Total voting rights

Following the issue of the new Ordinary Shares, the Company's issued share capital consists of 109,160,573 Ordinary Shares, with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

-ENDS-

 

Enquiries:

The Company

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

 

Beaufort Securities Limited (Broker)

Jon Belliss

Tel: +44 (0)20 7382 8300

 

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess/ Josh Cole

Tel: +44 (0) 7748 843 871

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFXSADEKEFF
Date   Source Headline
2nd Dec 20204:25 pmRNSChange of name to MyHealthChecked Plc
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSAcquisition of home-use genetic testing company
28th Sep 20207:00 amRNSHalf-year Report
22nd Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSCommercial update; Change of registered office
2nd Jul 20203:24 pmRNSResult of AGM
5th Jun 20207:01 amRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSNotice of Annual General Meeting
2nd Jun 20207:00 amRNSCommercial update
29th May 20207:00 amRNSFinal Results
4th May 20207:00 amRNSPartnership agreement with Abingdon Health
27th Apr 20208:16 amRNSDirector/PDMR Shareholding
24th Apr 202011:26 amRNSResult of GM & Completion of Fundraise
14th Apr 20209:27 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSManufacturing outsourcing agreements for myLotus®
8th Apr 20207:00 amRNSPlacing and Subscription to raise £1.9 million
29th Jan 20207:00 amRNSTrading Update
14th Nov 20197:00 amRNSBoard Appointments
13th Nov 20198:35 amRNSBoard changes - replacement
13th Nov 20197:00 amRNSBoard Changes
31st Oct 20197:00 amRNSConcepta announces first myLotus® UK birth
25th Oct 20197:00 amRNSBoard Changes
30th Sep 20197:00 amRNSFirst myLotus® UK Fertility Clinic collaboration
30th Sep 20197:00 amRNSInterim Results
29th Jul 20197:00 amRNSGrant of Options
9th Jul 20197:00 amRNSmyLotus® pregnancies in double figures
13th Jun 20192:01 pmRNSResult of AGM
21st May 20199:00 amRNSNotice of AGM
14th May 20197:01 amRNSAnnual Results
14th May 20197:00 amRNSConcepta announces first myLotus® pregnancies
30th Apr 20194:28 pmRNSHolding(s) in Company
30th Apr 20191:46 pmRNSTR-1: form for notification of major holdings
29th Apr 20191:20 pmRNSTR-1: notification of major holdings
26th Apr 201910:52 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSPlacing to raise £2.3m; Notice of General Meeting
29th Mar 20197:00 amRNSConcepta to supply myLotus® to Boots UK
12th Mar 20197:00 amRNSConcepta to supply myLotus® to Walgreens Boots
17th Dec 20187:00 amRNSmyLotus® successful UK launch
31st Oct 20187:00 amRNSmyLotus® launch at The Fertility Show, London
29th Oct 20187:00 amRNSmyLotus gains CE-mark regulatory approval
5th Oct 20182:42 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSGrant of Options
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:37 pmRNSPrice Monitoring Extension
27th Sep 20187:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.